Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization
Frontiers in Psychiatry · 13.05.2026 · 17
DOI: 10.3389/fpsyt.2026.1777387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Psychiatry, online erschienen am 13.05.2026. Verfasst von Feliciano Yu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, United States. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Importance The Oregon Psilocybin Services (OPS) program is the first statewide, regulated framework for legal psilocybin in the U.S. Analyzing inaugural-year utilization and safety is essential for informing policy and equity monitoring.
Methods
We conducted a descriptive analysis of statewide aggregate data from the OPS Public Dashboard (January 1–December 31, 2025). Outcomes included service volume, client demographics, motivations, and acute adverse events.
Results
In 2025, 5,935 clients participated in 5,375 sessions. Volume peaked in Q2 (n=1,758) before stabilizing in Q4 (n=1,358). Service tourism was significant, with 32.6% of participants residing outside Oregon. The largest segment was aged 35–49 (~40%); women (57.4%) and LGBTQ+ individuals (27.2%) represented substantial portions of the annual cohort. Racial diversity was limited, with White participants representing 84.1%–91.5% quarterly, while Hispanic/Latino (7.1%) and African American (2.1%) participation lagged. Adverse events were rare, with annual behavioral and medical rates of 2.42 and 2.79 per 1,000 sessions, respectively.
Discussion
Full-year data indicate stabilized utilization by a predominantly midlife adult population. While the program successfully reaches sexual and gender minorities, racial disparities persist. High service tourism suggests significant socioeconomic barriers. These findings underscore the program’s dual role as a wellness modality and a functional alternative for addressing mental health distress.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR, United States.
- Andrew Weil Center for Integrative Medicine, University of Arizona, Tucson, AZ, United States.
- College of Medicine, University of Arizona, Tucson, AZ, United States.
Zitieren
APA
Yu, F., Tafur, J., Moreno, F., & Dahmer, S. (2026). Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization. Frontiers in Psychiatry, 17. https://doi.org/10.3389/fpsyt.2026.1777387
Vancouver
Yu F, Tafur J, Moreno F, Dahmer S. Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization. Frontiers in Psychiatry. 2026;17. doi:10.3389/fpsyt.2026.1777387
BibTeX
@article{Yu2026,
author = {Yu, Feliciano and Tafur, Joe and Moreno, Francisco and Dahmer, Stephen},
title = {Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization},
journal = {Frontiers in Psychiatry},
year = {2026},
volume = {17},
doi = {10.3389/fpsyt.2026.1777387}
}
EUVIMED